Aoxing Pharmaceutical Company, Inc.
AOXG · OTC
6/30/2025 | 6/30/2024 | 6/30/2016 | 6/30/2015 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 26.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 75.9% | 77.7% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | – | – | 22.4% | 36.7% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | – | – | 6.4% | 21.6% |
| EPS Diluted | 0 | -0 | 0.03 | 0.09 |
| % Growth | 330.2% | -100.1% | -66.7% | – |
| Operating Cash Flow | – | -$0 | -$0 | $0 |
| Capital Expenditures | – | $0 | -$0 | -$0 |
| Free Cash Flow | – | -$0 | -$0 | $0 |